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An important prerequisite to myelination in peripheral nerves is the establishment of one-to-one relationships between axons and
Schwann cells. This patterning event depends on immature Schwann cell proliferation, apoptosis, and morphogenesis, which are gov-
erned by coordinated changes in gene expression. Here, we found that the RNA-binding protein human antigen R (HuR) was highly
expressed in immature Schwann cells, where genome-wide identification of its target mRNAs in vivo in mouse sciatic nerves using
ribonomics showed an enrichment of functionally related genes regulating these processes. HuR coordinately regulated expression of several
genes to promote proliferation, apoptosis, and morphogenesis in rat Schwann cells, in response to NRG1, TGF, and laminins, three major
signals implicated in thispatterning event. Strikingly,HuRalsobinds to severalmRNAsencodingmyelination-relatedproteinsbut, contrary to
its typical function, negatively regulated their expression, likely to prevent ectopic myelination during development. These functions of HuR
correlatedwith its abundance and subcellular localization, whichwere regulated by different signals in Schwann cells.
Introduction
The myelinating Schwann cells in the peripheral nervous system
(PNS) are derived from the neural crest via two transitional
stages. First, neural crest cells generate Schwann cell precursors,
which then give rise to immature Schwann cells that surround
large bundles of axons. Schwann cells then initiate radial sorting
of axons by selectively segregating large-diameter axons and es-
tablishing one-to-one relationships with them. This prerequisite
formyelination requires thematching of Schwann cell number to
axons by proliferation and apoptosis, and cytoskeletal-mediated
Schwann cell morphogenesis, processes controlled by three ma-
jor signals: Neuregulin-1 (NRG1), transforming growth factor-
(TGF), and laminins (Jessen and Mirsky, 2005; Woodhoo and
Sommer, 2008).
Global changes in gene expression accompany the profound
phenotypic changes associated with Schwann cell development.
Thus, genes associated with proliferation and apoptosis, which
reach a peak in immature Schwann cells, are highly expressed at
this stage. With subsequent development, as the cells exit the cell
cycle and lose susceptibility to apoptosis, these genes are
downregulated. Conversely, many myelination-related genes
are significantly upregulated as immature Schwann cells differ-
entiate into myelinating Schwann cells (Verheijen et al., 2003;
D’Antonio et al., 2006a). Recent studies have started to unravel
the transcriptional and posttranscriptional molecular mecha-
nisms that control these coordinated changes in gene expression.
Chromatin remodeling, via HDAC1 and HDAC2, and micro-
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RNAs have been shown to be essential for the control of Schwann
cell numbers and induction of myelination (Chen et al., 2011;
Dugas and Notterpek, 2011; Jacob et al., 2011).
Cytoplasmic control ofmRNA turnover and translation rates,
mediated by RNA-binding proteins (RBPs), is a major post-
transcriptional mechanism that promotes rapid and appropri-
ate spatiotemporal expression of encoded proteins in response
to environmental and internal cues. Human antigen R (HuR),
a member of the ELAV/Hu family of RBPs, is a ubiquitously
expressed protein that is essential for embryonic development
and plays an important role in a number of disorders, includ-
ing cancer (Hinman and Lou, 2008; Va´zquez-Chantada et al.,
2009). HuR binds to the U- and AU-rich elements in the 3-
untranslated region (UTR) of many mRNAs, generally pro-
moting their stability and translation (Lebedeva et al., 2011;
Mukherjee et al., 2011).
In this study, we found that HuR was highly expressed in
immature Schwann cells, where genome-wide identification of
its target mRNAs showed an enrichment of mRNAs encoding
proteins with functions in regulating proliferation, apoptosis,
and morphogenesis. Using in vitro silencing experiments, we
found that HuR contributed to enhancing the expression of
several genes induced by NRG1, TGF, and laminins, the
three major signals involved in these processes. Chromatin im-
munoprecipitation analysis showed that p65 and SMAD2/3 bind
to theHuR promoter in vivo to regulate its expression, likely to be
triggered by NRG1 and TGF, respectively. Significantly, we
found that HuR is a negative regulator of myelination since, al-
though it is bound to several mRNAs encoding myelination-
related proteins, it negatively regulated their expression. Finally,
we found that HuR protein is greatly reduced in vivo as myelina-
tion progresses, a process likely to be controlled by Egr2-
mediated ubiquitin proteolysis.
Materials andMethods
Animals. Mice and rats of either sex were housed at the Animal Unit at
CIC bioGUNE, and all procedures were approved by the institutional
review committee on animal use. TheAnimalUnit ofCICbioGUNE is an
Association for Assessment and Accreditation of Laboratory Animal
Care-accredited facility.
RNA immunoprecipitation. Immunoprecipitation (IP) protocol of en-
dogenous mRNA-transfected HuR complexes was performed as de-
scribed by Keene et al. (2006). In brief, 500 g of whole-cell lysate
obtained from a pool of newborn (NB) or postnatal day 5 (P5) sciatic
nerves from C57BL/6J mice of either sex were incubated with a suspen-
sion of protein A-Sepharose beads (Sigma-Aldrich), precoated with 15
g of either IgG1 (BD Biosciences Pharmingen) or anti-HuR (Santa
Cruz Biotechnology) antibodies. For RNA immunoprecipitation (RIP)-
chip analysis, appropriate amounts of total RNA from four biological
replicates of HuR andmock IPs, as well as two replicates of input mRNA
from NB and P5 nerves were submitted to the Genomics Analysis Plat-
form at CIC bioGUNE for analysis on MOUSE WG-6 V2 arrays (Illu-
mina). For RIP–quantitative PCR (qPCR) analysis, bound mRNA was
measured by real-time PCR analysis, normalized to GAPDH mRNA
bound in a nonspecific manner to IgG1.
Microarray analysis and gene ontology classification. Data were ex-
tracted using BeadStudio data analysis software.Datawere processed and
normalized using Robust Spline normalization using Lumi bioconduc-
tor package (Du et al., 2008). The data for the probes with a detection p
value0.01 were excluded. Those detected with p value0.01 in at least
one array were accepted as significant. For the detection of differentially
expressed genes, a linearmodel was fitted to the data and empirical Bayes
moderated t statistics were calculated using the limma package from
Bioconductor. Adjustment of p values was done by the determination of
false discovery rates using Benjami–Hochberg procedure (Peart et al.,
2005; Smyth, 2005). Biological functional analysis was performed using
the Ingenuity Pathway Analysis software (Ingenuity Systems). Fisher’s
exact test was performed with the p value threshold of 0.05 to identify
molecular functional categories with statistical significance.
Biotin pull-down assay. Biotinylated transcripts were synthesized using
cDNAthatwasprepared fromsciatic nerves.Templateswerepreparedusing
forwardprimers that contained theT7RNApolymerase promoter sequence
(CCAAGCTTCTAATACGACTCACTATAGGAGA), as described previ-
ously (Li et al., 2002). Biotin pull-down assays were performed as described
previously (Antic and Keene, 1997), and bound proteins were analyzed by
Western blotting. In brief, the PCR-amplified fragments were purified and
used as templates for in vitro synthesis of the corresponding biotinylated
RNAs by MAXIscript kit (Applied Biosystems). Biotin pull-down assays
were performed by incubating 40 g of P5 sciatic nerve cell lysates with
equimolar amounts of biotinylated transcripts for 1 h at room temperature.
The complexes were isolated using paramagnetic streptavidin-conjugated
Dynabeads (Invitrogen), andboundproteins in thepull-downmaterialwere
analyzed by Western blotting using an antibody recognizing HuR. Primer
sequences are available on request.
RNA isolation and qPCR. RNA was isolated with Trizol (Invitrogen),
and its concentration and integrity were determined. qPCRs were per-
formed using Bio-Rad iCycler thermocycler. Ct values were normalized
to the housekeeping expression (GAPDH ). Primer sequences are avail-
able on request.
Protein isolation and Western blotting. Isolation and Western blotting
of total proteins from cells and nerves were done as described previously
(Parkinson et al., 2008). Subcellular fractions were isolated using the
Proteoextract Subcellular Proteome Extraction kit (Calbiochem), ac-
cording to manufacturer’s instructions. The purity of cytoplasmic and
nuclear fractions was examined by Western blotting in each experiment
using antibodies to Gapdh and Histone H3, respectively.
Rat primary Schwann cell culture. Sciatic nerves obtained from P3
Wistar rats of either sex were digested in 0.25% trypsin, 0.4% collagenase
in DMEM, and cultured for 3 d in DMEM with 10% fetal bovine serum
(FBS) containing AraC (103 M). After 3 d in culture, Schwann cells were
immunopanned to remove remaining fibroblasts and expanded in
DMEM/F12, 3% FBS, NRG1 (10 ng/ml), N2 supplement, and forskolin
(4 M). Only the first five passages were used. For proliferation experi-
ments, cells were first cultured overnight in Minimal Medium (MM)
(DMEM/F12, 5% FBS, and N2 supplement) before NRG1 (20 ng/ml) or
TGF (2 ng/ml) stimulation at appropriate time points. For cell shape
experiments, cells were cultured overnight in MM before replating onto
poly-L-lysine (PDL)- or laminin-coated dishes. For apoptosis assays,
freshly isolated Schwann cells from NB nerves were isolated, plated onto
coverslips in Simple Medium (SM) [DMEM/F12 and BSA (0.3 mg/ml
final)], and treated with TGF (2 ng/ml) for 48 h. Recombinant human
TGF1 and NRG-1 (Heregulin-1 isoform) were purchased from
PeproTech and R&D Systems, respectively.
Neuron–Schwann cell cocultures. Myelinating neuron–Schwann cell
cocultures were prepared by adding purified rat Schwann cells, infected
with shHuR lentivirus or adenovirus expressingHuR, to purified E15 rat
DRG neurons. Myelination was induced with 50 mg/ml ascorbic acid,
and myelin basic protein (MBP) antibodies were used to label myelin
segments or RNA extracted (Parkinson et al., 2008).
Viral infection. ForHuRknockdown, cellswere treatedwith short-hairpin
lentiviral particles againstHuR (CCGGCCCACAAATGTTAGACCAATTC
TCGAGAATTGGTCTAACATTTGTGGGTTTTTG) in the presence of
hexadimethrine bromide (8 g/ml). After 24 h transduction, the cells were
selected using puromycin (1.25 g/ml) and puromycin-resistant HuR-
knockdown cell clones were grown, analyzed, and frozen for future use. For
adenoviral infections, cells were cultured in MM, adenoviral particles were
added (amount added determined by titration), and 24 h later the medium
waschanged.Adenoviral constructsusedwereas follows:GFP/Krox-20(Ad-
K20) and its matched GFP control (Ad-GFP) (a gift from J. Milbrandt,
Department of Genetics, Washington University School of Medicine, St.
Louis, MO) (Parkinson et al., 2004), SMAD7 (Ad-SMAD7) (Blaney David-
son et al., 2006), and HuR (Ad-HuR) (Xiao et al., 2007).
Inhibitors. Specific inhibitors in our culture experiments were obtained
from Calbiochem and were used at the following concentrations: 10 M
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1,4-diamino-2,3-dicyano-1,4-bis(2-aminophe-
nylthio)butadiene (U0126) (ERK1/2 inhibitor),
10 M 4-[4-(4-fluorophenyl)-2-(4-methyl-
sulfinylphenyl)-1H-imidazol-5-yl]pyridine
(SB203580) (p38 inhibitor), 10 M 2-(4-mor-
pholinyl)-8-phenyl-4H-1-benzopyran-4-one
(LY294002) (PI3K inhibitor), 10MN-(benzy-
loxycarbonyl)leucinylleucinylleucinal (MG132)
(proteosome inhibitor), and 2 M 3-[(4-methyl-
phenyl)sulfonyl]-(2E)-propenenitrile (BAY11-
7082) (NF-B inhibitor).
Migration assay. Migration using the
“scratch assay” was performed as described
previously (Liang et al., 2007). In brief, control
andHuR-silenced cells were seeded onto PDL-
or laminin-coated dishes and cultured over-
night in MM. A scratch was performed using a
p200 pipette tip, culturemediumwas changed,
and pictures were taken at time 0, 6, 12, 18, and
24 h. The gap distance was measured at each time point, and data were
expressed as percentage gap distance over time.
cAMP myelination assay. A cAMP analog, dibutryl-cAMP (Sigma-
Aldrich) was added to cultures (103 M), and protein or mRNA was
obtained 24 h later.
Immunohistochemistry and immunocytochemistry. For teased nerves,
nerves were dissected out, immediately fixed in 4% PFA for 10 min,
teased on microscope slides, and allowed to dry. The samples were incu-
bated in 0.2% Triton in blocking solution (BS) (PBS containing 10% calf
serum, 0.1% lysine, and 0.02% sodium azide) followed by overnight
incubation at 4°C with the following primary antibodies: HuR (1:100)
and TUJ1 (1:5000) followed by secondary antibodies conjugated with
FITC or Cy3 (Cappel/Jackson ImmunoResearch Laboratories). Talin
immunocytochemistry has been described previously (Nodari et al.,
2007), and in vitro BrdU incorporation and TUNEL labeling described
previously (Parkinson et al., 2001; D’Antonio et al., 2006b). Images were
acquired with an AxioImager D1 fluorescent microscope (Zeiss).
Chromatin immunoprecipitation. Rat Schwann cells or whole nerves
were cross-linked with 1% formaldehyde (v/v) at 25°C for 10 min. After
sonication into 200–500 bp fragments using Bioruptor (Diagenode),
chromatin was immunoprecipitated with 2 g of anti-p65 antibody (sc-
372; Santa Cruz Biotechnology) or 5g of anti-Smad2/3 antibody (3102;
Cell Signaling Technology) using theMagna ChIP G kit (Millipore). The
recoveredDNAwas subjected to PCR amplification. Chromatin that was
immunoprecipitated withmouse IgGwas used as a negative control. The
abundance of target genome DNA was calculated as the percentage of
input. Primer sequences are available on request.
Antibodies. Antibodies used were from the following: HuR and p65
(Santa Cruz Biotechnology), Gapdh (Abcam),-actin and Talin (Sigma-
Aldrich), p-ERK1/2, p-AKT, p-p38, Smad2/3 (Cell Signaling Technol-
ogy), Egr2 and TuJ1 (Covance), MPZ (Astexx), Periaxin (gift from P.
Brophy, Centre for Neuroregeneration, University of Edinburgh, Edin-
burgh, UK), and MBP (Eurogentec). Fluorescent-conjugated secondary
antibodies were from Jackson ImmunoResearch, and HRP-conjugated
secondary antibodies were from Bio-Rad.
Assessment of mRNA stability. mRNA stability was determined by ac-
tinomycin D chase experiments, following a standard protocol described
previously (Chang et al., 2010). Briefly, control and HuR-silenced cells
were treated with db-cAMP for 24 h, which significantly increased ex-
pression of all mRNAs analyzed. Actinomycin D was added to a final
concentration of 5g/ml to block further transcription. At 0, 30, 60, 120,
and 240min after actinomycin D treatment, the cells were harvested and
mRNA was quantified by qPCR. The mRNA decay was recorded as the
percentage of mRNA remaining over time compared with the amount
before the addition of actinomycin D.
Statistical analysis. All data are presented as arithmetic mean SEM,
unless otherwise stated. Statistical significance was estimated by Stu-
dent’s t test.
Results
HuR is highly expressed in immature Schwann cells
HuR is a ubiquitously expressed RBP that binds to and regulates
expression of thousands of mRNAs (Lebedeva et al., 2011;
Mukherjee et al., 2011), playing fundamental roles in prolifera-
tion, apoptosis, and differentiation in several systems and cell
types (Hinman and Lou, 2008). To investigate whether HuR
might have a role in Schwann cell development, we first exam-
ined its expression in rat sciatic nerves at different ages, as imma-
ture Schwann cells differentiate into myelinating Schwann cells
(Woodhoo et al., 2009).
We found that HuR mRNA was highly expressed in NB
nerves, which contain mostly immature Schwann cells, and P5,
which contain a mixture of immature Schwann cell and actively
myelinating Schwann cells. There was a small but significant
downregulation in P10 nerves, which contain an enriched popu-
lation of actively myelinating Schwann cells (Fig. 1a). This was
confirmed by examining its expression in total protein extracts
(Fig. 1b), although the decrease at protein level seen at P10
(70% by densitometry analysis) was much more significant
than at mRNA level (25%). A similar pattern of expression was
found when nuclear and cytoplasmic protein subcellular frac-
tions were analyzed (Fig. 1c). We confirmed that HuR was ex-
pressed in Schwann cells by immunohistochemistry in P5 teased
nerves (Fig. 1d).
Our results indicate that HuR may have a functional role in
early postnatal nerves since its abundance and cytoplasmic ex-
port both critically control expression of its target genes (Hinman
and Lou, 2008).
RIP-chip identifies several HuR target genes
To examine the biological significance of the high levels ofHuR in
NB and P5 Schwann cells, we analyzed themRNAs bound to it on
a genome-wide scale. For this, IP of ribonucleotide complexes
(ribonucleoproteins) from cytoplasmic lysates of freshly isolated
NB and P5 mouse sciatic nerves using an affinity-purified HuR
antibody was performed, followed by purification and genome-
wide microarray analysis of bound mRNAs (RIP-chip).
Two populations of mRNAs were detected in our analysis: an
enriched population corresponding to the HuR-bound mRNAs
and a nonenriched population representing background (control
IP using mouse IgG) (Fig. 2a). To identify transcripts signifi-
cantly associated with HuR, we used median log ratios of signal
from RNA immunoprecipitation with HuR antibody versus the
control IgG. HuR bound to 275 and 90 transcripts in NB and P5
nerves, respectively (Fig. 2b,c). Next, we examined the relation-
Figure 1. HuR is differentially expressed in postnatal sciatic nerves. HuR expression is significantly reduced in P10 nerves,
compared with NB and P5, as shown by qPCR (a), Western blotting of total protein extracts (b), and cytosolic and nuclear protein
fractions (c).d, Immunohistochemistry showingHuRexpression (red) in Schwann cells fromP5 teased sciatic nerves (arrows). TuJ1
labels axons (green) andDAPI labels nuclei (blue).b, c, Gapdh/-actin, Loading control. c, Gapdh, Cytoplasmicmarker; HistoneH3,
nuclear marker. Data are mean SEM. *p 0.01.
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ship between the levels of each HuR-bound transcript relative to
its total cellular level. There was little correlation between the
probability of HuR association and the transcriptome, with only
25%of total identified transcripts (HuR IP/IgG IP) found to be
significantly enriched relative to total mRNA levels (HuR IP/
input) in both cases (Fig. 2b). This shows that detection of tran-
scripts inHuR IP fraction is not dependent onmRNA abundance
and that there is no bias toward identification of highly abundant
or transcribed genes, as shown in other systems (Hieronymus and
Silver, 2003; Mukherjee et al., 2009).
Comparison of the identified transcripts in the NB and P5
nerves showed that approximately two-thirds of targets identified
in P5 nerves were commonly present in NB nerves, whereas the
large majority of transcripts identified in NB nerves were
uniquely expressed (Fig. 2c). Using the data set of gene expression
profiling in nerves of mice at different ages across the Schwann
cell lineage (Verheijen et al., 2003), we found that25% of these
unique HuR targets in NB nerves were also significantly down-
regulated in older nerves compared with NB nerves (50 of 215).
Since it was proposed that RBPs coordinate the expression
of transcripts encoding biologically related proteins (Keene,
2007), we performed Gene Ontology (GO) analyses of differ-
entially regulated HuR mRNA targets in NB and P5 nerves.
Functional classification into molecular and cellular function
(MF) showed that most of the enriched genes fell into several
categories related to proliferation, apoptosis, andmorphogen-
esis (Fig. 2d).
To validate our results from the RIP-chip analysis, fresh IPs
were performed, and expression of several genes related to pro-
liferation, apoptosis, and morphogenesis was quantified by
quantitative RT-PCR (RIP-qPCR). We found that, with some
rare exceptions, there was a similar trend of enrichment of these
HuR targets using both analyses (Table 1). Our RIP-chip analysis
also revealed a significant enrichment ofmRNAs encoding RBPs,
includingHuR itself, and Thoc4 andHnrpl among others, in line
with other studies (Pullmann et al., 2007; Mansfield and Keene,
2009). This was confirmed by RIP-qPCR for selected genes (data
not shown).
In summary, we find that HuR is bound to several mRNA
targets in peripheral nerves in vivo, with decreasing binding af-
Figure 2. RIP-ChIP identifies several HuR targets in vivo in NB and P5 nerves. a, Heat map showing expression of the top transcripts most significantly bound to HuR compared with control IgG
in NB nerves (top panel) and P5 nerves (bottom panel) in four different replicates (1–4). b, Heat map showing relative enrichment of top 50mRNA targets of HuR, compared with control IgG (HuR
IP/IgG IP, column 1) and input mRNA (HuR IP/Input, column 2). The color scale indicates the degree of enrichment (green–red ratio scale). c, Venn diagram showing the overlap of HuR-bound
transcriptswith a fold change1.5 in lysates isolated fromNBandP5nerves.d, EnrichedGO classification of the genes identified by theRIP-chip analyses inNB (blue histograms) andP5nerves (red
histograms).
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finity as development proceeds. The identified targets generally
fall into categories that most closely characterize the immature
Schwann cell stage (i.e., proliferation, apoptosis, and motility/
morphogenesis), suggesting that HuRmay have a functional role
in regulating these processes.
HuRmediates laminin-inducedmotility and morphogenesis
As mentioned above, before myelination, immature Schwann
cells migrate extensively along axons and send processes
within axon families to segregate and ensheath them. Laminin,
one of the critical components of the basal lamina, plays a
fundamental role in this process (Chernousov et al., 2008;
Feltri et al., 2008).
To examine whether HuR mediated laminin-induced func-
tion in Schwann cells, we used a lentiviral vector to silence HuR
(see Fig. 7b for effectiveness of HuR knockdown) and examined
its effect on migration andmorphogenesis. Using the cell scratch
assay, we found that the migratory rate on laminin substrate was
reduced in HuR-silenced cells compared with control cells (Fig.
3a,b), whereas no such effect was seen on PDL substrate, which
promotes non-receptor-specific cell adhesion (data not shown).
Similarly, on laminin substrate but not on PDL, HuR-silenced
cells spread less and elaborated fewer lamellipodia than control
cells (Fig. 3c,d). The length of axial lamellipodia on laminin sub-
strate, which favors directional cell migration (Pankov et al.,
2005), was reduced after HuR silencing (Fig. 3e), likely causing
the defects in migratory rates seen above. In addition, we found
that there was reduction in number of radial lamellipodia (Fig.
3e), which are important for the insertion of processes within
axons during radial sorting (Nodari et al., 2007). These results
show that HuR is an important mediator of laminin-induced
function in Schwann cells.
Next, we investigated the mechanisms involved in these pro-
cesses. First, by qPCR, we examined the expression of several of
the validated HuR targets, associated with cell movement and
morphogenesis in Schwann cells or in other systems, including
Pfn1 (Witke, 2004), Marcks (Larsson, 2006), Igfbp5 (Yano et al.,
1999), Ncam1 (Yu et al., 2009), Actin (Chernousov et al., 2008),
Ahnak (Salim et al., 2009), Lamc1 (Chen and Strickland, 2003),
and Calm3 (Larsson, 2006). We found that culture on laminin
substrate, compared with PDL, upregulated expression of several
of theseHuR targets (Fig. 3f).Ahnak, Lamc1, andCalm3were not
regulated by laminin (data not shown). Using RIP-qPCR analy-
ses, we also found that culture on laminin substrate significantly
increased binding of HuR to only the regulated mRNAs (Fig. 3g)
and that HuR silencing reduced their expression (Fig. 3h), likely
explaining the defects in laminin function.
HuR-mediated stabilization and translational upregulation of
target mRNAs are closely linked to its subcellular localization. It
is predominantly (90%) localized in the nucleus but, in re-
sponse to different stimuli, is exported to the cytoplasm, a process
modulated by several posttranslationalmodifications, which also
affects its binding to target mRNAs (Doller et al., 2008). We
found that laminin increased the nucleo-cytoplasmic translo-
cation of HuR (Fig. 4a), an effect controlled by p38 phosphor-
ylation (Fig. 4b), which has previously been shown to be
important for laminin-induced cell shape changes (Fragoso et
al., 2003; Berti et al., 2011). Treatment with the p38 inhibitor
also significantly reduced Schwann cell migration on laminin
substrate (Fig. 4c).
In summary, we show that laminin induces translocation of
HuR from the nucleus to the cytoplasm and increases HuR-
mediated stabilization of several mRNAs that regulate cell motil-
ity and morphogenesis in Schwann cells.
Table 1. Validation of RIP-ChIP by RIP-qPCR
Gene symbol Gene name
NB P5
Array qPCR Array qPCR
Proliferation
Ccnd1 Cyclin D1 5.54* 5.17* 1.32 n.s. 1.12 n.s.
Ccnd2 Cyclin D2 1.56* 2.31* 1.41 n.s. 1.19 n.s.
Cdk2 Cyclin-dependent kinase 2 2.55* 3.35* 1.29 n.s. 1.63 n.s.
Serpine2 Serine (or cysteine) peptidase inhibitor, clade E, member 2 1.78* 3.74* 1.04 n.s. 1.61 n.s.
Brd4 Bromodomain containing 4 2.13* 3.73* 1.29 n.s. 1.12 n.s.
Erbb2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 1.76* 5.17* 1.00 n.s. 1.09 n.s.
Sox9 SRY-box containing gene 9 3.38* 7.86* 1.70* 3.93*
Shc1 Src homology 2 domain-containing transforming protein C1 3.19* 6.52* 1.35 n.s. 1.09 n.s.
Cell morphology
Actb Actin, beta 59.1* 63.9* 26.3* 29.5*
Ncam1 Neural cell adhesion molecule 1 2.34* 4.65* 1.38 n.s. 1.06 n.s.
Pfn1 Profilin 1 3.98* 4.65* 5.56* 5.08*
Ahnak AHNAK nucleoprotein (desmoyokin) 16.5* 12.7* 6.79* 6.89*
Lamc1 Laminin, gamma 1 2.32* 4.45* 1.06 n.s. 1.35 n.s.
Calm3 Calmodulin 3 6.62* 16.1* 2.66* 7.18*
Igfbp5 Insulin-like growth factor binding protein 5 4.29* 3.86* 1.69 n.s. 1.51 n.s.
Marcks Myristoylated alanine-rich protein kinase C substrate 4.57* 9.83* 1.15 n.s. 1.60 n.s.
Apoptosis
Casp2 Caspase 2 1.99* 5.11* 1.14 n.s. 1.87 n.s.
Casp9 Caspase 9 1.89* 3.68* 1.32 n.s. 1.68 n.s.
Aatk Apoptosis-associated tyrosine kinase 7.08* 12.6* 2.74* 5.20*
Btg1 B-cell translocation gene 1 2.82* 4.71* 1.13 n.s. 1.58 n.s.
Map3k1 Mitogen-activated protein kinase kinase kinase 1 1.7* 4.51* 1.12 n.s. 1.14 n.s.
Cd44 CD44 antigen 1.99* 6.24* 1.47 n.s. 5.01*
Pdcd4 Programmed cell death 4 2.57* 8.60* 2.11* 7.48*
Vdac1 Voltage-dependent anion channel 1 3.09* 6.14* 1.82 n.s. 3.63*
p 0.05; n.s., not significant.
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HuRmediates NRG1- and TGF-induced proliferation
Immature Schwann cell proliferate vigorously during late embry-
onic to perinatal stages (Stewart et al., 1993), a process thought to
be critical for radial sorting and dependent on axonally derived
mitogens, including NRG1 and TGF (Chernousov et al., 2008;
Feltri et al., 2008; Woodhoo and Sommer, 2008).
Using established cell culture conditions that promote the
mitogenic effect of NRG1 and TGF in vitro (Atanasoski et al.,
2004), we found that HuR silencing significantly reduced prolif-
eration induced by these two growth factors (Fig. 5a,b). The per-
centage of BrdU cells was significantly reduced from 77.6 
2.7% in control cells to 44.6  2.5% in HuR-silenced cells after
NRG1 treatment, and from30.1 1.5 to 17.8 1.1% after TGF
treatment (p 0.01). To investigate the mechanisms involved in
this function of HuR, we first examined expression of HuR tar-
gets associatedwith proliferation, includingCyclinD1 (Kim et al.,
Figure 3. HuRmediates laminin-induced HuRmotility andmorphogenesis. a, Cell scratch assay showing that migration on laminin-coated coverslips is significantly reduced in sh HuR-infected
cells (**) compared with sh control-infected cells (*). b, Graphs showing the closure of the gap distance with time after culture on laminin-coated coverslips. c, Talin immunocytochemistry (red)
showingmorphological differences between sh HuR-infected and sh control-infected cells plated onto laminin. d, HuR-silenced cells have a smaller surface area and fewer lamellipodia on laminin
substrate, but not on PDL. e, HuR-silenced cells have shorter axial lamellipodia and fewer radial lamellipodia than sh control-infected cells on laminin. f, qPCR showing expression of different
transcripts after culture on lamininwith time, expressed as fold change relative to cells replated onto PDL dishes.g, RIP-qPCR analysis shows significant enrichment of severalmotility/morphology-
associated genes bound toHuR in cells plated onto laminin comparedwith cells plated onto PDL.h,HuR silencing leads to a significant reduction in expression of these genes. Data aremean SEM.
*p 0.01.
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2000), Cyclin D2 (Jena et al., 2002), Cdk2
(Tikoo et al., 2000), Serpine 2 (Lino et al.,
2007), Shc1 (Ward et al., 1999), Sox9 (Lin-
coln et al., 2007), Erbb2 (Raphael et al.,
2011), andBrd4 (Houzelstein et al., 2002).
We found that NRG1 and TGF treat-
ment upregulated expression of several of
these targets (Fig. 5c). RIP-qPCR analysis
showed that NRG1 and TGF treatment
significantly increased HuR binding to
these mRNAs (Fig. 5d), the expression of
which were significantly reduced by HuR
silencing (Fig. 5e,f). We also found that
NRG1 and TGF promoted the nucleo-
cytoplasmic translocation of HuR (Fig.
6a). ERK1/2 and AKT phosphorylation
controlled both NRG1-induced translo-
cation of HuR and proliferation (Fig. 6b),
whereas ERK1/2 and p38 phosphoryla-
tion controlled TGF-induced transloca-
tion of HuR and proliferation (Fig. 6c).
In summary, we show that HuR in-
creases stability of genes in response to
NRG1 and TGF, regulating their func-
tion on proliferation.
HuRmediates TGF-induced apoptosis
Natural cell death, like proliferation, is a feature of immature
Schwann cells, which is induced by TGF in vivo (D’Antonio et
al., 2006b).
Using established cell culture conditions that promote the
apoptotic effect of TGF in Schwann cells (Parkinson et al.,
2001), we found that silencing of HuR significantly reduced ap-
optosis (Fig. 7a,b). The percentage of surviving cells increased
from29.5 8.5% in control cells to 68.5 7.8% inHuR-silenced
cells, whereas the percentage of apoptotic TUNEL cells de-
creased from 49.2 6.7 to 13.5 2.3% (p 0.01). Of note, these
culture conditions are different fromproliferation-inducing con-
ditions (above). To investigate themechanisms involved, we first
examined expression of HuR targets associated with apoptosis,
including Aatk (Tomomura et al., 2001), Btg1 (Lee et al., 2003),
Caspase 2 (Kumar, 2009), Caspase 9 (Riedl and Salvesen, 2007),
Vdac1 (Shoshan-Barmatz et al., 2010), Pdcd4 (Lankat-Buttgereit
and Go¨ke, 2009), Map3k1 (Parkinson et al., 2004), and Cd44
(Rouschopet al., 2006).We foundthatTGF treatmentupregulated
expression of several of theseHuR targets (Fig. 7c). RIP-qPCR anal-
ysis showed that TGF treatment significantly increasedHuR bind-
ing to them (Fig. 7d), the expression of which was significantly
reduced by HuR silencing (Fig. 7e). We also found that TGF in-
duced the nucleo-cytoplasmic translocation of HuR (Fig. 7f), an
effect controlled by p38 phosphorylation but not by ERK1/2 phos-
phorylation, which was not activated in these culture conditions
(Fig. 7g). Treatment with specific inhibitors also had a similar effect
on TGF-induced apoptosis (Fig. 7h).
Thus, we show that TGF-induced apoptosis is controlled by
HuR-mediated stabilization of several apoptosis-related genes.
HuR is a negative regulator of
myelination
In our RIP-chip analysis, we found severalmyelination-related pro-
teins (e.g., Pmp22,Mpz) encodedbymRNAswhose abundancewas
enriched inHuR IP samples, especially at theNB stage (Fig. 2b).We
confirmed this observation for the Pmp22 gene by RIP-qPCR (Fig.
8a) and showed thatHuR specifically bound to its 3-UTRby biotin
pull-downassays (Fig. 8b).ByRIP-qPCR,wealsovalidated thebind-
ing of HuR to other myelination-related mRNAs (i.e., Egr2, Prx,
Mbp,Mpz) with significantly decreased binding affinity in P5 nerves
(Fig. 8c). This was a surprising observation since this pattern is in-
versely correlated to their totalmRNA levels, which increase postna-
tally reaching a peak at approximately P10 (Verheijen et al., 2003).
To further examine the role of HuR in the process of myeli-
nation, we silencedHuR in cultured Schwann cells and examined
expression of some of these myelination-related proteins byWest-
ern blotting.HuR silencing induced a significant increase in their
levels, both under myelinogenic conditions and strikingly under
basal conditions aswell (Fig. 8d). By qPCRanalysis, we also found
increased levels of myelination-related mRNAs afterHuR silenc-
ing both under basal (Fig. 8e) and myelinogenic conditions (Fig.
8f), which was opposite to its effects seen above for
morphogenesis-, proliferation-, and apoptotic-related genes. Ex-
posure to actinomycin D in cAMP-treated cells showed that the
half-life of each mRNA was significantly longer in HuR-silenced
cells than control cells (Fig. 8g), suggesting that HuR could be
destabilizing these mRNAs, instead of its typical role as a stabiliz-
ing factor for target mRNAs.
These data indicate that HuR could be a negative regulator of
myelination (Jessen andMirsky, 2008). To show this, we examined
myelination in dorsal root ganglion (DRG) cocultures, seeded with
Schwann cellswith altered levels ofHuR.We found thatHuR silenc-
ing significantly increased the number of MBP segments in the
cocultures (16.5 2.1% inHuR-silenced cells comparedwith 8.1
1.6% in control cells; p 0.01) (Fig. 9a), accompanied by a signifi-
cant increase in transcript expression (Fig. 9b). Conversely, en-
forced expression of HuR by adenoviral vectors decreased the
number of MBP segments (5.9 0.6% in control cells com-
pared with 4.3 0.4% in HuR-overexpressing cells; p 0.05)
(Fig. 9c), accompanied by a small but significant decrease in
the expression of some of these transcripts (Fig. 9d).
The above data argue for a potential role of HuR in inhibiting
myelination, similar to Notch and c-Jun (Parkinson et al., 2008;
Woodhoo et al., 2009).
Figure4. Laminin induces nucleo-cytoplasmic translocation ofHuR.a,Western blot showingnucleo-cytoplasmic translocation
of HuR after replating of Schwann cells onto laminin. b, c, Western blot showing that treatment with SB203580 (to block p38
phosphorylation) prevents the nucleo-cytoplasmic translocation of HuR after 4 h culture onto laminin (b) and reduces the migra-
tion rate on laminin (c).a,b,-Actin, Loading control.a, Gapdh, Cytoplasmicmarker; Histone H3, nuclearmarker. Cyto, Cytoplas-
mic fractions; Nucl, nuclear fractions.
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HuR transcription is regulated by p65 and Smad2/3
HuR abundance plays a critical role in its function (Hinman and
Lou, 2008). We showed that HuR mRNA levels decrease with
development (Fig. 1a), and we wanted to examine the mecha-
nisms that control this.
It has previously been shown in other systems thatHuR tran-
scription is positively regulated by the transcription factors (TFs)
NF-B (Kang et al., 2008) and Smads (Jeyaraj et al., 2010). We
tested the recruitment of NF-B to the HuR promoter in chro-
matin extracts fromNB, P5, and P10 nerves by chromatin immu-
noprecipitation (ChIP) using antibodies against the p65 subunit
of NF-B followed by qRT-PCR.We found significant binding of
p65 to different putative consensus sites, with reduced affinity in
P10 nerves compared with NB or P5 nerves (Fig. 10a). ChIP of
Smad2/3 showed similar results (Fig. 10b), whereas no recruit-
ment was seen with ChIP of Smad4 (data not shown). The de-
creased binding of p65 or Smad2/3 to the HuR promoter in P10
nerves is likely due to reduced nuclear expression of these TFs in
these nerves (Fig. 10c).
Next, we examined the signaling pathways that could poten-
tially regulate this mechanism. It was previously shown that
NRG1 is sufficient to activate NF-B in Schwann cells (Limpert
Figure 5. HuRmediates NRG1- and TGF-induced proliferation. a, b, HuR silencing significantly reduces NRG1- (a) and TGF-induced (b) proliferation compared with sh control-infected cells
as determined by BrdU incorporation (BrdU cells, red; DAPI nuclei, blue). c, qPCR showing expression of different transcripts after NRG1 or TGF treatment with time, expressed as fold change
relative to untreated cells. d, RIP-qPCR analysis shows significant enrichment of proliferation-associated genes bound to HuR in NRG1- and TGF-treated cells compared with cells cultured in MM.
e, f, HuR silencing leads to a significant reduction in expression of proliferation-associated genes after NRG1 (e) and TGF (f ) treatment. Data are mean SEM. *p 0.01.
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andCarter, 2010).We thus testedwhether
NRG1 was responsible for p65-mediated
HuR transcription. We found that NRG1
treatment induced a transient increase in
HuR mRNA and protein levels (Fig. 10d)
and ChIP experiments showed that p65
was recruited to the HuR promoter after
treatment with NRG1 for 1 h, but not for
12 h (Fig. 10e), following the kinetics of
NRG1-induced HuR transcription (Fig.
10d). NRG1-induced increase inHuR lev-
els was significantly attenuated by treat-
ment with the NF-B-specific inhibitor
BAY11-7082, which prevents nuclear lo-
calization of p65 (Fig. 10f), confirming
the role of NF-B in NRG1-inducedHuR
transcription.
Similarly, we found that TGF, which
induces nuclear translocation of Smad2/3
in Schwann cells (D’Antonio et al.,
2006b), increased HuR mRNA and pro-
tein levels (Fig. 10g) and ChIP of Smad2/3
showed its recruitment to the HuR pro-
moter after treatment for 1 h, but not 12 h
later (Fig. 10h), following the kinetics of
NRG1-induced HuR transcription (Fig.
10g). TGF-induced increase in HuR lev-
els was significantly attenuated by en-
forced expression of Smad7 by adenoviral
infection (Ad-Smad7), which prevents
phosphorylation of Smad2/3 and its sub-
sequent activation and translocation (Fig. 10i), confirming the
role of Smad2/3 in TGF-inducedHuR transcription. Combined
treatment of NRG1 and TGF did not lead to an enhanced up-
regulation of HuR levels seen by separate treatments of these
growth factors at 2 h (Fig. 10j) and at 4 h (data not shown).
Laminin treatment also had no effect onHuR transcription (data
not shown).
Our data show that HuR transcription is dependent on the
TFs NF-B and Smad2/3 in vivo, likely to be regulated by NRG1
and TGF, respectively. Reduced expression of these TFs results
in decreased HuRmRNA levels during development.
Egr2 (Krox20) induces proteosomal degradation of HuR
Earlier, we found thatHuR protein levels were significantly reduced
in P10 nerves compared with NB or P5 nerves, whereas there was
only a slight reduction in mRNA levels (Fig. 1a–c). Since we found
previously that the TF Egr2, which plays a critical role in the myeli-
nation process (Topilko et al., 1994), can also suppress expression of
several negative regulators of myelination, including Notch and
c-Jun (Parkinson et al., 2008; Woodhoo et al., 2009), we examined
whether it was responsible for this downregulation of HuR expres-
sion.We found that enforced Egr2 expression was sufficient to sup-
press HuR protein levels (Fig. 10k) without affecting mRNA levels
(data not shown). This effect was dependent on the ubiquitin-
proteosomal degradation pathway since treatment with the proteo-
some inhibitorMG132 diminished this effect (Fig. 10l).
Discussion
Radial sorting plays a critical role in PNS myelination. We show
that the RNA-binding protein HuR is highly expressed during
this stage, where it is bound to and regulates expression of nu-
merous genes regulating proliferation, apoptosis, and morpho-
genesis. This supports the view that RBPs such as HuR perform
their overall biological functions by coordinately regulating ex-
pression of multiple functionally related mRNAs, known as
“RNA operons” (Keene, 2007). This association of HuR with
mRNAs is dynamic, with a significant decrease in the population
of target mRNAs in P5 nerves compared with NB nerves, coin-
ciding with a general decrease in mRNA expression of some of
them (Verheijen et al., 2003). This is in line with other studies,
which show dynamic changes in the association of HuR with
target mRNAs (Mazan-Mamczarz et al., 2008; Mukherjee et al.,
2009), and supports the view that RNA accessibility partially de-
termines the formation of RBP–mRNA complexes (Kazan et al.,
2010).
Schwann cell morphogenesis
Laminins play a major role in radial sorting with severe defects
seen after in vivo ablation of laminin isoforms, receptors, and
downstream signaling pathways (Chernousov et al., 2008; Feltri
et al., 2008). Our data suggest that HuR could be an important
mediator of laminin-induced function in Schwann cells by bind-
ing to and stabilizing laminin-inducedmRNAs.HuR silencing in
vitro results in decreased migration and significantly leads to
morphological phenotypes, similar to cells lacking the laminin
receptor 1-integrin or its downstream effector Rac1 (Benninger
et al., 2007; Nodari et al., 2007). This effect is likely controlled by
p38-mediated nucleo-cytoplasmic translocation of HuR, which
is an important determinant of its function (Doller et al., 2008).
Schwann cell proliferation
Schwann cell proliferation is critical for matching axon and Schwann
cell numbers during radial sorting, a process dependent on ax-
onally derived mitogens (Chernousov et al., 2008; Feltri et al.,
Figure 6. NRG1 and TGF induce nucleo-cytoplasmic translocation of HuR.a,Western blot showing nucleo-cytoplasmic trans-
location of HuR after NRG1 and TGF treatment. b, Treatment with U0126 (to block ERK1/2 phosphorylation) or LY294002 (to
block AKT phosphorylation) prevents NRG1-induced nucleo-cytoplasmic translocation of HuR (left panel) and proliferation (right
panel). c, Treatment with U0126 or SB203580 prevents TGF-induced nucleo-cytoplasmic translocation of HuR (left panel) and
proliferation (right panel). a– c, -Actin, Loading control. a, Gapdh, Cytoplasmic marker; Histone H3, nuclear marker. Cyto,
Cytoplasmic fractions; Nucl, nuclear fractions. Data are mean SEM. *p 0.01.
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Figure 7. HuRmediates TGF-induced apoptosis. a, b, HuR silencing leads to a significant reduction in TGF apoptosis as seen by number of surviving cells identified by nuclear condensation
viewed by DAPI (blue) and number of apoptotic cells viewed by TUNEL labeling (green) (a), andWestern blot of PARP cleavage and active caspase-3, 48 h after treatment (Figure legend continues.)
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2008; Woodhoo and Sommer, 2008). NRG1 is likely to play a
major role, as shown in vitro (Morrissey et al., 1995) and in vivo in
zebrafish (Lyons et al., 2005; Raphael et al., 2011). Indirect evi-
dence also exists in mice models in vivo, as shown in mutants
lacking the downstream effector of NRG1 signaling Cdc42 (Ben-
ninger et al., 2007) and in mice with neuronal overexpression of
NRG1 (Gomez-Sanchez et al., 2009). TGF is another important
Schwann cell mitogen, both in vitro (Atanasoski et al., 2004) and
in vivo (D’Antonio et al., 2006b).We show that NRG1 and TGF
increase expression and binding of HuR to several proliferation-
associated genes. HuR silencing decreases expression of these
genes and consequently proliferation. Both signals induce
nucleo-cytoplasmic translocation of HuR, an effect mediated by
several kinases such as ERK1/2, which also regulate proliferation,
in line with other studies for NRG1 (Maurel and Salzer, 2000;
Echave et al., 2009) andTGF (Xie et al., 2007). This suggests that
these kinases could regulate proliferation induced by these two
growth factors, by increased nucleo-cytoplasmic translocation of
HuR and stabilization of critical target genes.
Schwann cell apoptosis
TGF is also a death signal for Schwann cells (D’Antonio et al.,
2006b).We show that it increases expression and binding ofHuR
4
(Figure legend continued.) (b). c, qPCR showingexpressionofdifferent transcripts after TGF
treatment with time, expressed as fold change relative to untreated cells. d, RIP-qPCR analysis
shows significant enrichment of apoptosis-associated genes bound to HuR in TGF-treated
cells compared with cells cultured in SM. e, HuR silencing leads to a significant reduction in
expression of these genes. f, Western blot showing nucleo-cytoplasmic translocation of HuR
after TGF treatment. g, h, Treatment with SB203580, but not with U0126, prevents TGF-
induced nucleo-cytoplasmic translocation of HuR (g) and apoptosis (h). f, g,-Actin, Loading
control. f, Gapdh, Cytoplasmicmarker; Histone H3, nuclearmarker. Cyto, Cytoplasmic fractions;
Nucl, nuclear fractions. Data are mean SEM. *p 0.01.
Figure 8. HuR is a negative regulator of myelination. a, RIP-qPCR analysis shows binding of HuR to Pmp22mRNA both in NB and P5 nerves. b, Schematic of Pmp22mRNA depicting the 5-UTR,
coding region, and 3-UTR. In silico analysis revealed several computationally predicted HuR motifs (arrowheads), and biotinylated transcripts spanning different mRNA regions (A–E) were
incubated with P5 sciatic nerve lysates and the interaction assessed by biotin pull-down assays followed byWestern blot analysis. HuR only formed complexes with a specific region of the 3-UTR,
but not with the 5-UTR or coding region. No interaction was seen with a control biotinylated RNA corresponding to the 3-UTR of GAPDHmRNA, which is not a target of HuR (data not shown). c,
RIP-qPCR analysis shows binding of HuR to several myelination-related genes in postnatal nerves. d, Western blot showing an increased expression of several myelination genes afterHuR silencing
under basal (MM) andmyelinogenic conditions (dibutryl-cAMP treatment). e, f, qPCR showing an increased expression of myelination-related genes after HuR silencing in MM (e), and after cAMP
treatment (f). g, qPCR showing the half-life of myelination-related genes in control and HuR-silenced cAMP-treated cells. Data are mean SEM. *p 0.01.
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to several apoptosis-associated genes. HuR silencing decreases
expression of these genes and consequently apoptosis. This effect
is likely mediated by an increased nucleo-cytoplasmic transloca-
tion of HuR, induced by TGF-mediated p38 phosphorylation,
an important determinant of its function on apoptosis, as shown
here and in other systems (Liao et al., 2001). It is quite striking
that HuR mediates the effects of one single factor in two such
distinct processes as proliferation and apoptosis. It has been pro-
posed that TGF acts as a mitogen for cells in close contact with
axons and an apoptotic signal for cells that have lost contact with
axons (D’Antonio et al., 2006b). Such a context could explain the
dual role of HuR; TGF, in concert with other mitogens such as
NRG1 and laminins, would induce ERK1/2-mediated cytoplasmic
localization of HuR and/or increase binding to and stability of
proliferation-associated genes. Upon loss of axonal contact, TGF,
alone or in concert with other death signals, would induce p38-
mediated cytoplasmic localization of HuR and/or increase binding
to and stability of apoptosis-associated genes.
Negative regulator of myelination
Our RIP-chip analysis identified a number of myelination-
related genes as HuR targets (e.g., Egr2, Pmpm22, Mpz) in NB
nerves, which was surprising since these genes are upregulated
later in development. Further analysis suggests that HuR, in con-
trast to its typical function, decreases their stability and transla-
tion. This is in agreement with recent reports, which also show
that HuR can destabilize target mRNAs such as p16(INK4) and
Daf (Chang et al., 2010; Gray et al., 2010) and repress translation
of genes such as p27 (Hinman and Lou, 2008). This function of
HuR is likely to prevent ectopic expression of myelin genes in
immature Schwann cells before they segregate into 1:1 relation-
ship with axons, such that myelin is not abnormally formed
around axon–Schwann cell families. With subsequent develop-
ment, as most of the promyelin Schwann cells are formed, HuR
no longer binds to and destabilizes these genes as shown by RIP-
chip analysis of P5 nerves, allowing myelination to proceed
normally.
The mechanisms that lead to this
switch in binding affinity of HuR to
these mRNAs at different stages of de-
velopment could be regulated by differ-
ent posttranslation modifications
(Doller et al., 2008). Thus, in NB nerves,
a specific posttranslational modifica-
tion of HuR (e.g., phosphorylation)
could make it amenable to binding to
these mRNAs. After radial sorting, ei-
ther loss of this modification and/or a
different modification, in response to
myelination signals, could prevent its
binding to these mRNAs. In addition,
HuR abundance, which also determines
its function (Hinman and Lou, 2008),
could be another important factor in
regulating this switch. In P10 nerves,
which correspond to stages of peak of
myelination, HuR levels are consider-
ably decreased. Thus, the low levels of
HuR could also explain its decreased
binding to the myelin protein-related
mRNAs.
Control of HuR expression
Finally, we show that the TFs NF-B and Smad2/3 are bound to
specific sites in the HuR promoter in vivo, as shown in other
systems (Kang et al., 2008; Jeyaraj et al., 2010). The decreased
expression of HuR mRNA levels in P10 nerves is likely due to a
reduced activation of these TFs, as shown previously for NF-B
(Nickols et al., 2003), resulting in a decreased binding to theHuR
promoter. We also identify NRG1 and TGF as the signals that
respectively recruit NF-B and Smad2/3 to the HuR promoter.
This is likely to be important in vivo to maintain high levels of
HuR in early postnatal nerves.
In addition, HuR has been found to autoregulate its levels by
binding to HuR mRNA, stabilizing it (Al-Ahmadi et al., 2009),
and enhancing its cytoplasmic export (Yi et al., 2010). In our
RIP-chip assay, we found an enrichment of HuRmRNA in both
NB and P5 nerves, showing that HuR is likely to be regulating its
stability during Schwann cell development. We also found a sig-
nificant reduction of HuR protein in P10 nerves, which is un-
likely to be due to the small decrease in HuR mRNA levels. We
show instead that this could depend on ubiquitin-proteosomal
degradation, as described previously (Abdelmohsen et al., 2009),
mediated by the transcription factor Egr2, which similarly re-
presses expression of other negative regulators of myelination,
including Notch (Woodhoo et al., 2009), and c-Jun and Sox2
(Parkinson et al., 2008). miRNAs could also potentially play a
significant role in this process since HuR translation can be
blocked by two different miRNAs, miR-519 (Abdelmohsen et al.,
2008) and miR-125a (Guo et al., 2009), and miRNAs play a sig-
nificant role in radial sorting, proliferation, and apoptosis during
early postnatal Schwann cell development (Dugas and Notter-
pek, 2011).
In vivo functions of HuR?
It would be important to examine HuR function in vivo. Since
HuR knock-out mice are embryonically lethal (Katsanou et al.,
2009), Schwann cell-specific ablation of HuR would need to be
performed using established cre mouse lines (Woodhoo et al.,
2009). These mice could be characterized by peripheral nerve
Figure 9. HuR regulates myelination in DRG cocultures. a, b, HuR silencing increases myelination in Schwann cell-DRG cocul-
tures, as seen by number of MBPmyelin segments (red) (a), and qPCR analysis of myelination-related genes (b). c, d, Enforced
HuR expression induced a small but significant decrease in myelination in Schwann cell-DRG cocultures, as seen by number of
MBPmyelin segments (red) (c), and qPCR analysis of myelination-related genes (d). Gapdh, Loading control. Data aremean
SEM. *p 0.01.
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defects, including impairment in radial sorting and/or premature
myelination, given the range of features, such as laminin-induced
morphological functions that HuR controls in immature
Schwann cells in vitro. This would be similar to mice lacking
different laminin isoforms, laminin receptors, and downstream
targets such as Rac1 (Chernousov et al., 2008; Feltri et al., 2008).
These pleiotropic functions of HuR and the range of mRNAs it
interacts with, also raise the possibility that it could have impor-
tant functions in adult nerves, controlling features such as de-
differentiation. Following nerve injury, for example, Schwann
cells de-differentiate to a phenotype closely resembling immature
Schwann cells (Jessen andMirsky, 2008). They downregulatemy-
elination genes, break down their myelin, and proliferate rapidly,
and some of the supernumerary ones undergo apoptosis (Yang et
al., 2008). HuR could be mediating injury-induced responses of
Schwann cells, including proliferation and apoptosis, as some of
Figure 10. HuR expression is controlled by p65 and Smad2/3-induced transcription. a, b, Schematic diagram of the promoter region of HuR showing NF-B consensus binding sites
(green ovals) and regions analyzed (A1 and A2) (a) and SMAD2/3 consensus binding sites (yellow ovals) and regions analyzed (B1 and B2) (b). ChIP analysis shows a decreased binding
of p65 and SMAD2/3 to the regions analyzed, in P10 nerves compared with NB and P5 nerves. c, Western blot showing reduced p65 and SMAD2/3 expression in nuclear fractions of P10
nerves compared with NB and P5 nerves. d–f, NRG1 increases HuR transcription through NF-B activation. d, Treatment with NRG1 increases HuR mRNA (top panel) and HuR protein
levels (bottom panel), as seen by qPCR and Western blotting, respectively. e, ChIP analysis shows that p65 is recruited to the HuR promoter regions (indicated in a) after treatment with
NRG1 for 1 h, but not in cells cultured in MM, or with NRG1 for 12 h. f, Western blot showing that treatment with the NF-B inhibitor BAY11-7082, which prevents the nuclear
translocation of p65, inhibits the NRG1-induced increase in HuR levels. g–i, TGF increases HuR transcription through SMAD2/3 activation. g, Treatment with TGF increases HuRmRNA
(top panel) and HuR protein levels (bottom panel), as seen by qPCR and Western blotting, respectively. h, ChIP analysis shows that SMAD2/3 is recruited to the HuR promoter regions
(indicated in b) after treatment with TGF for 1 h, but not in cells cultured in MM, or with TGF for 12 h. i, Western blot showing that adenoviral infection of cells with SMAD7 adenovirus
(Ad-SMAD7), which prevents the nuclear translocation of SMAD2/3, inhibits the TGF-induced increase in HuR levels. j, Combined treatment of NRG1 and TGF of Schwann cells plated
onto laminin did not lead to an enhanced upregulation of HuR, induced by the two growth factors alone, as seen by qPCR (top panel) andWestern blot (bottom panel), 2 h after treatment.
k, l, Western blots showing that adenoviral infection of cells with Egr2 adenovirus (Ad-Egr2) decreases HuR levels after 48 h (k), an effect reduced with treatment with the proteosome
inhibitor MG132 (l). -Actin/Gapdh, Loading control. Nuc, Nuclear fractions. Data are mean SEM. *p 0.01.
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the identified HuR targets in Schwann cells such as Cyclin D1 are
reexpressed upon injury and have important physiological func-
tions during the de-differentiation process (Kim et al., 2000; Ata-
nasoski et al., 2001).
Notes
Supplemental material for this article is available at http://www.ebi.ac.
uk/arrayexpress/experiments/E-MEXP-3519. Raw and processed mi-
croarray data are publicly accessible at EMBO-EBI ArrayExpress
database under accession number E-MEXP-3519. This material has not
been peer reviewed.
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